Endoscopic Stricture Management Device Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Endoscopic Stricture Management Device Market size was valued at USD 881 million in 2023 and is expected to reach USD 1.4 billion by 2032 growing at a CAGR of 5.8% over the analysis period. The market is driven by several factors, including ongoing technological advances in endoscopic stricture management devices, increasing prevalence of diseases leading to strictures, and increasing awareness towards early diagnosis of strictures. Additionally, increase in minimally invasive surgical procedures using endoscopes is also driving the demand for endoscopic stricture management devices globally.
The growing occurrence of conditions that result in strictures, such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), colorectal cancer, and biliary diseases is fuelling the need for efficient endoscopic interventions. According to a study published by British Medical Journal in February 2023, total cases of IBD during 1990 – 2019 increased by about 47.45%. Endoscopic stricture management devices offer a less invasive approach to treating strictures that occurs due to such gastric disorders. As a result, with the growing prevalence of gastric disorders such as IBD and GERD, the demand for endoscopic stricture management devices is increasing globally.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Endoscopic Stricture Management Device Market size in 2023: | USD 881 Million |
Forecast Period: | 2024 – 2032 |
Forecast Period 2023 - 2032 CAGR: | 5.8 |
2023 Value Projection: | USD 1.4 Billion |
Historical Data for: | 2021 – 2023 |
No of Pages: | 190 |
Tables, Charts & Figures: | 293 |
Segments Covered: | Product, Application, End User, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Based on the Product, the global market is classified into stents, balloon dilators, bougie dilators, and other products. The stents segment is further segmented into metal stents, plastic stents, and biodegradable stents. The stents segment has asserted its dominance in the global market by securing a significant share and experiencing growth of 6% between 2024 – 2032.
Based on the application, the endoscopic stricture management device market is classified into esophageal, colonic, pyloric, biliary, and other applications. The esophageal segment held the largest market share of 36.6% in 2023. This dominance can be attributed to high incidence of strictures caused in esophageal region due to gastric diseases such as GERD; esophageal cancer; eosinophilic esophagitis; IBD, and corrosive injuries.
Based on the end user, the endoscopic stricture management device market is classified into hospitals, ambulatory surgery centers, and other end users. The hospital segment is expected to reach USD 827.3 million by 2032.
North America region is projected to maintain its lead in the endoscopic stricture management device market, anticipated to reach USD 543.6 million by 2032.
The market is fragmented with the presence of several established market players and new entrants. Also, the market players are emphasizing towards developing innovative and advanced products that can offer enhanced biocompatibility, improved fit, and better safety to the patients.
In this dynamic environment, fierce competition drives companies to distinguish themselves through product innovation, branding, and strategic marketing efforts to cater to the increasing demand for endoscopic stricture management devices.
Prominent players operating in the endoscopic stricture management device industry are as mentioned below:
Market, By Product
Market, By Application
Market, By End User
The above information is provided for the following regions and countries:
Endoscopic stricture management device market was valued at USD 881 million in 2023 and is set to reach USD 1.4 billion by 2032, driven by growing occurrence of conditions that result in strictures, such as gastroesophageal reflux.
The esophageal application segment held the 36.6% of the endoscopic stricture management device industry share in 2023 and is set to grow rapidly by 2032, owing to high incidence of strictures caused in esophageal region.
North America endoscopic stricture management device market held a robust share in 2023 and is set to reach USD 543.6 million by 2032, owing to rising incidence of diseases such as GERD.
Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical Inc., Becton, Dickinson and Company, Merit Medical Systems, Medi-Globe GmbH, PanMed Us, HOBBS MEDICAL, INC., Micro-Tech (Nanjing) Co., Ltd among others.